Article Type
Changed
Tue, 09/25/2018 - 09:44
Display Headline
Pitfalls, pearls, and practicalities in the diagnosis of Helicobacter pylori infection
Article PDF
Author and Disclosure Information

Gary Falk, MD
Department of Gastroenterology & Hepatology, Cleveland Clinic Foundation, Cleveland, OH

Leonard Ehrlich, MD
George Washington University School of Medicine, Washington, DC

A. Mark Fendrick, MD
Division of General Medicine, University of Michigan Health System, Ann Arbor, Ml

M. Brian Fennerty, MD
Division of Gastroenterology, Oregon Health & Science University, Portland, OR

Ben Gold, MD
Division of Pediatric Gastroenterology and Nutrition, Emory University School of Medicine, Atlanta, GA

Nimish Vakil, MD
University of Wisconsin Medical School and Marquette College of Health Sciences, Milwaukee, WI

Derek van Amerongen, MD, MS
Chief Medical Officer, Humana Health Plan of Ohio, Cincinnati, OH

David Wyatt, MD
Eagles Landing Family Practice, McDonough, GA

Gary Falk, MD, has served as a consultant to AstraZeneca Pharmaceuticals and Meridian Bioscience.

Brian Fennerty, MD, has served as a consultant to AstraZeneca Pharmaceuticals, Eisai, Meridian Bioscience, Santarus, and TAP Pharmaceutical Products.

Ben Gold, MD, has served as a consultant to AstraZeneca Pharmaceuticals, Meridian Bioscience, Meretek Diagnostics, and TAP Pharmaceutical Products.

Nimish Vakil, MD, has received grant/research support from AstraZeneca Pharmaceuticals, Medtronic, Novartis, and Pfizer; has served as a consultant to AstraZeneca, Medtronic, Meridian Bioscience, and Novartis; and is on the speakers’ bureaus of AstraZeneca, Novartis, and TAP Pharmaceutical Products.

Leonard Ehrlich, MD, A. Mark Fendrick, MD, Derek van Amerongen, MD, and David Wyatt, MD, have served as consultants to Meridian Bioscience.

Publications
Page Number
S14-S21
Author and Disclosure Information

Gary Falk, MD
Department of Gastroenterology & Hepatology, Cleveland Clinic Foundation, Cleveland, OH

Leonard Ehrlich, MD
George Washington University School of Medicine, Washington, DC

A. Mark Fendrick, MD
Division of General Medicine, University of Michigan Health System, Ann Arbor, Ml

M. Brian Fennerty, MD
Division of Gastroenterology, Oregon Health & Science University, Portland, OR

Ben Gold, MD
Division of Pediatric Gastroenterology and Nutrition, Emory University School of Medicine, Atlanta, GA

Nimish Vakil, MD
University of Wisconsin Medical School and Marquette College of Health Sciences, Milwaukee, WI

Derek van Amerongen, MD, MS
Chief Medical Officer, Humana Health Plan of Ohio, Cincinnati, OH

David Wyatt, MD
Eagles Landing Family Practice, McDonough, GA

Gary Falk, MD, has served as a consultant to AstraZeneca Pharmaceuticals and Meridian Bioscience.

Brian Fennerty, MD, has served as a consultant to AstraZeneca Pharmaceuticals, Eisai, Meridian Bioscience, Santarus, and TAP Pharmaceutical Products.

Ben Gold, MD, has served as a consultant to AstraZeneca Pharmaceuticals, Meridian Bioscience, Meretek Diagnostics, and TAP Pharmaceutical Products.

Nimish Vakil, MD, has received grant/research support from AstraZeneca Pharmaceuticals, Medtronic, Novartis, and Pfizer; has served as a consultant to AstraZeneca, Medtronic, Meridian Bioscience, and Novartis; and is on the speakers’ bureaus of AstraZeneca, Novartis, and TAP Pharmaceutical Products.

Leonard Ehrlich, MD, A. Mark Fendrick, MD, Derek van Amerongen, MD, and David Wyatt, MD, have served as consultants to Meridian Bioscience.

Author and Disclosure Information

Gary Falk, MD
Department of Gastroenterology & Hepatology, Cleveland Clinic Foundation, Cleveland, OH

Leonard Ehrlich, MD
George Washington University School of Medicine, Washington, DC

A. Mark Fendrick, MD
Division of General Medicine, University of Michigan Health System, Ann Arbor, Ml

M. Brian Fennerty, MD
Division of Gastroenterology, Oregon Health & Science University, Portland, OR

Ben Gold, MD
Division of Pediatric Gastroenterology and Nutrition, Emory University School of Medicine, Atlanta, GA

Nimish Vakil, MD
University of Wisconsin Medical School and Marquette College of Health Sciences, Milwaukee, WI

Derek van Amerongen, MD, MS
Chief Medical Officer, Humana Health Plan of Ohio, Cincinnati, OH

David Wyatt, MD
Eagles Landing Family Practice, McDonough, GA

Gary Falk, MD, has served as a consultant to AstraZeneca Pharmaceuticals and Meridian Bioscience.

Brian Fennerty, MD, has served as a consultant to AstraZeneca Pharmaceuticals, Eisai, Meridian Bioscience, Santarus, and TAP Pharmaceutical Products.

Ben Gold, MD, has served as a consultant to AstraZeneca Pharmaceuticals, Meridian Bioscience, Meretek Diagnostics, and TAP Pharmaceutical Products.

Nimish Vakil, MD, has received grant/research support from AstraZeneca Pharmaceuticals, Medtronic, Novartis, and Pfizer; has served as a consultant to AstraZeneca, Medtronic, Meridian Bioscience, and Novartis; and is on the speakers’ bureaus of AstraZeneca, Novartis, and TAP Pharmaceutical Products.

Leonard Ehrlich, MD, A. Mark Fendrick, MD, Derek van Amerongen, MD, and David Wyatt, MD, have served as consultants to Meridian Bioscience.

Article PDF
Article PDF
Related Articles
Page Number
S14-S21
Page Number
S14-S21
Publications
Publications
Article Type
Display Headline
Pitfalls, pearls, and practicalities in the diagnosis of Helicobacter pylori infection
Display Headline
Pitfalls, pearls, and practicalities in the diagnosis of Helicobacter pylori infection
Citation Override
Cleveland Clinic Journal of Medicine 2005 May;72(suppl 2):S14-S21
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Tue, 09/25/2018 - 09:15
Un-Gate On Date
Tue, 09/25/2018 - 09:15
Use ProPublica
CFC Schedule Remove Status
Tue, 09/25/2018 - 09:15
Article PDF Media